Key Market Indicators
**New Zealand's Antiinfective Medicine Market to Hit $68 Million by 2028** New Zealand's antiinfective medicine sales are projected to climb from approximately $63 million in 2023 to nearly $68 million by 2028. This growth represents an average annual increase of 1.3%. Despite this upward trend, the market has seen a historical decline, decreasing by 7.5% annually since 1998. In 2023, New Zealand ranked 12th globally in antiinfective medicine sales, with Slovakia surpassing it by matching New Zealand's $63 million. Spain, Croatia, and Australia secured the 2nd, 3rd, and 4th positions, respectively, in the global rankings. **Antibiotics Import Growth in New Zealand** New Zealand's antibiotics import is on a modest rise, anticipated to reach $7.3 million by 2028, up from $6.9 million in 2023. This growth reflects a compound annual growth rate (CAGR) of 0.7%. The demand for antibiotics in New Zealand has been increasing at an annual rate of 1.7% since 1994. **Exports of Antibiotics from New Zealand on the Rise** The export of antibiotics from New Zealand is expected to grow significantly, projected to reach $11.3 million by 2028, compared to $9.7 million in 2023. This indicates a CAGR of 2.3%. Since 1994, New Zealand's supply of antibiotics has been growing at an annual rate of 3.9%.
